PapiX™ high Purifying gel
ACNEIC AND ACNE PRONE SKIN
Help your patients regain their confidence with a clinically proven effective 1st line treatment option.
PapiXTM high
Purifying gel 2
PapiXTM high helps reduce seborrhea production and improve acneic lesions within 30 days of use3
MEDICAL DEVICE
Salicylic acid 3
Urea peroxide 3
Zinc gluconate 3
Taurine 3
Formulated without silicons, vegetable or mineral oils and petroleum jelly which could increase sebum production3
PROVEN EFFICACY IN INDUCING SIGNIFICANT IMPROVEMENT IN ACNE LESIONS OVER 30 DAYS OF TREATMENT 1+
Global Clinical Impressions score after 30 days of using 3 PapiXTM products in combination
Evidence of efficacy in 90% of the cases
PapiX™ Range
significant improvement in acne lesions WITH high tolerability and pleasantness of use1
Dermatologically tested3,4,5
Not photosensitising3,4
Non comedogenic5
Help your patients regain their confidence with a clinically proven effective 1st line treatment option.
+Clinical observational study conducted on 200 volunteers, both male and female, who were suffering from mild to moderate facial acne. The study protocol included two observational levels: T0 and T1 (30 days of treatment). Efficacy was measured according to the Global Acne Grading System (GAGS). The safety and acceptability were evaluated using a Global Clinical Impressions score (the Investigator Global Assessment: IGA) performed at T1 (after 30 days of treatment). The IGA score was rated as follows: 0 = no improvement, 1 = moderate improvement, 2 = marked improvement, 3 = clear-cut improvement/disappearance of baseline lesion/condition. Regarding pleasantness and ease of application, at T1 the volunteers were asked to give their impressions using a semi-quantitative score (Poor, Sufficient, Fair, Good and Excellent). In 76% of the volunteers treated during this study, no associated systemic therapy was administered while 14% received oral antibiotics and 3.5% estroprogestinics.
- Rigoni C et al. Clinical observational study of the topical treatment of mild to moderate acne. J Plastic Dermatology 2016; 12: 1-5.
- PapiX high labelling
- PapiX high PIL
- PapiX long PIL
- PapiX cleanser labelling